Latest news


Mandatory notification regarding exercise and trade of subscription rights

Posted on Sep 20, 2018

Oslo, September 20, 2018 – Overview of mandatory notification regarding exercise and trade of subscription rights. Management and the board of directors of PCI Biotech Holding ASA (“PCI Biotech” or “the Company”) are all supportive to the share issue resolved by the extraordinary general meeting 14 September 2018. In total the transactions disclosed herein leads […]

Mandatory notification regarding exercise and trade of subscription rights

Posted on Sep 20, 2018

The Chairman Hans Peter Bøhn has today, 19 September 2018, subscribed for 40,106 new shares in PCI Biotech Holding ASA (the “Company”) at a subscription price of NOK 30 per share by exercising all his 40,106 subscription rights allocated in the Company’s ongoing rights issue. After the transaction, Hans Peter Bøhn will have a total […]

Commencement of subscription period

Posted on Sep 20, 2018

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, HONG KONG OR SOUTH AFRICA, OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE […]